MCL1 and pancreatic neoplasm: We therefore assessed Mcl-1 expression in pancreatic cancer cell lines of varying aggressiveness (S2-VP10, AsPC-1, MIA PaCa-2) and compared the levels to that in normal human pancreatic ductal cells (HPDEC).